25.8.2021 08:45:01 CEST | Aqua Bio Technology ASA | Additional regulated information required to be disclosed under the laws of a member state
First half year highlights – ready for rollout in the markets:
Aqua Bio Technology (ABT) has signed distribution agreements for Norway, Denmark, New Zealand and Australia for distribution of Moana and B Natural.
Hydrafacial announced a partner agreement with Restorsea and the launch of the Restorsea Lip Fix Kit based on Aquabeautine XL.
Completion of second payment for exclusive world-wide rights for the Moana Skincare brand.
First order for Moana Skincare from DBK Pharmaceuticals S.A.E. confirmed.
Confirmation from Al Dawaa Pharmacies that they are ready to distribute Moana Skincare to pharmacies in Saudi Arabia after registration with the authorities, starting with 50 pharmacies.
Private placement in Q2 provided the company with approximately NOK 15 million.
Launched 3 new trading platforms for Seiðr, Seiðr Clinique and B Natural, respectively.
Launched new website for ABT and B2B for distributors.
Launched 44 new natural skincare products and three new skincare series, with a high content of natural and active ingredients (11 Sei∂r, 28 Sei∂r clinique, 15 products B Natural).
Improvement of revenues in the first half of 2021 vs the same period in 2020.
Major investments made to support and secure the production and launch of ABT’s new natural skincare products.
Significantly increased activity from Restorsea, which has global rights to ABT’s patented and key ingredient Aquabeautine XL.
The pandemic has affected ABT’s producers, suppliers and distributors, but the vaccination rate in various countries is reopening several of the markets.
The company’s revenues in the first half of 2021 were NOK 0.7 million against NOK 0.3 million in the same period last year. About 30% of the income in the period was royalty income from the collaboration with American Restorsea. Other income was from the sale of skincare products. Cost of goods related to skincare products amounted to NOK 1.0 million in the first half of the year, compared with almost NOK 0.6 million in the same period last year. The company’s operating costs (excluding cost of goods) were NOK 8.1 million in the first half of 2021. In the same period last year, operating costs were NOK 7.2 million. EBITDA for the first half of 2021 was NOK -8.4 million, which is weaker compared with the corresponding period last year, when EBITDA was NOK -7.5 million. ABT’s profit after tax was NOK -9.4 million, compared with NOK -6.4 million in the first half of 2020.
The equity ratio at the end of the first half of the year was 50.50%, compared to 22.60% after the first half of 2020.
* * *
For further information, please contact CEO Håvard Lindstrøm mobile phone 0047 941 32 288.
Aqua Bio Technology (ABT) is developing and commercializing sustainable biotechnology for use in skincare products. ABT’s cosmetics ingredients are highly effective and they provide the cosmetics industry with natural alternatives to traditional ingredients. ABT is also marketing and distributing natural skincare products developed by partners towards consumers and professional users. ABT’s focus on commercialization and development of natural ingredients and natural skincare products has been, and will continue to be, an important part of the Company’s strategy going forward. Aqua Bio Technology is listed on the Euronext Expand market of the Oslo Stock Exchange. This information is such that Aqua Bio Technology ASA is required to disclose in accordance with the EU Market Abuse Regulation, and is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
Disclosure regulation
This information is subject of the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act.
Contacts
Håvard Lindstrøm, 004794132288, hl@aquabiotech.no
About Aqua Bio Technology ASA
Aqua Bio Technology (ABT) is developing and commercializing sustainablebiotechnology for use in skin care products. ABT’s cosmetics ingredients arehighly effective and they provide the cosmetics industry with naturalalternatives to traditional ingredients. ABT is also marketing and distributingnatural skin care products developed by partners towards consumers andprofessional users. Aqua Bio Technology is listed on Euronext Expand.
Attachments
Download announcement as PDF.pdf
ABT halvarsrapport 25 august 2021.pdf
